A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

Samaritan Medical Center has announced that its Pain Management Center will close its door at the end of next month. In an ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.